INSIGHTS ON CLINICAL TRIAL DESIGN
-
![glp1 thumb]( "The Golden Era Of GLP-1 Drugs")
The Golden Era Of GLP-1 DrugsAs GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.
-
![GettyImages-1196710772 doctors]( "Why Ophthalmology Assessments Are Non-Negotiable")
Why Ophthalmology Assessments Are Non-NegotiableLearn about the challenges researchers face when incorporating ophthalmology assessments into clinical trials, and how you can address those obstacles to the benefit of your trial and its participants.
-
![Medable patient expo]( "Together, We Are On A Mission: Enabling Treatments To Reach Patients")
Together, We Are On A Mission: Enabling Treatments To Reach PatientsThis AI-powered digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.
-
![GettyImages-1830134683 patient nurse]( "The Crucial Role Of Mobile Visits In A DCT For Interstitial Lung Disease")
The Crucial Role Of Mobile Visits In A DCT For Interstitial Lung DiseaseDecentralized clinical trials (DCTs) are revolutionizing patient participation by bringing clinical research directly to participants' homes through mobile research nurses.
-
Ophthalmology Assessments Made Simple: A Guide For Clinical Trials1/29/2025
Explore the importance and requirements of ophthalmology assessments as well as the key challenges that complicate their implementation at clinical sites.
-
Gene, Cell, And RNA Therapy Landscape Continues To Thrive3/21/2025
The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.
-
It's A Mad Men World For IRB Review Of Clinical Trial Advertisements7/13/2026
Modern digital tools and AI have transformed clinical trial recruitment, outpacing decades-old regulations. Discover how to apply core ethical principles to protect participant privacy and equity.
-
Providing Access To Patients9/9/2025
We believe that delivering meaningful results begins with meeting patients where they are — whether in their homes, within their communities, or in familiar gathering places.
-
Mastering Scope 3 Emissions In Clinical Trials10/23/2024
Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1135573728-digital-patient-tablet-recruitment]( "Enhance Clinical Trial Screening And Improve Patient Matching Accuracy")
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
![GettyImages-1132766141 patient recruitment]( "A New Blueprint For Transforming Feasibility And Recruitment")
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
![Doctor talking to patient-GettyImages-1330555438]( "Supporting Patients For Better Clinical Trials")
From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
-
![GettyImages-953449116 clinical trial oversight]( "Smarter Oversight, Earlier Action")
When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.
-
![GettyImages-1483234004-opthalmology-machine-eye-exam]( "Post-Marketing Studies And Real-World Evidence Clinical Trials")
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
